Research programme: GLP-1 receptor agonists - Poxel
Latest Information Update: 28 Nov 2020
Price :
$50 *
At a glance
- Originator Poxel
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Glucagon-like peptide-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 28 Nov 2020 No recent reports of development identified for research development in Type-2-diabetes-mellitus in France (PO)
- 21 Oct 2016 GLP-1 receptor agonists are still in Early research phase for Type-2 diabetes mellitus in France (Poxel pipeline)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in France (PO)